Klotman Mary E.
SEC CIK 2020575 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | Dir | 2,211 | — | — | 3 | 2024-05-31 | 2026-05-19 |
Most active insiders at AMGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Santos Esteban | EVP, Ops | — | $20.77M |
| 2 | Grygiel Nancy A. | SVP, CCO | — | $2.65M |
| 3 | Gordon Murdo | EVP, Gbl Commercial Ops | — | $2.32M |
| 4 | Khosla Rachna | SVP, Business Development | — | $1.65M |
| 5 | Miller Derek | SVP, Human Resources | — | $1.57M |
| 6 | Busch Matthew C. | VP, CAO, Fin | — | $375.8K |
| 7 | Klotman Mary E. | Dir | — | — |
| 8 | Bradner James E. | EVP, Research, Development | — | — |
| 9 | Drake Michael V | Dir | — | — |
| 10 | Griffith Peter H. | EVP, CFO | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 19:05 | 2026-05-19 | AMGN | Amgen | Klotman Mary E. | Dir | A - Grant | $0.00 | +665 | 2,211 | +43% | $0 | |
| 2025-05-28 | 2025-05-23 | AMGN | Amgen | Klotman Mary E. | Dir | A - Grant | $0.00 | +809 | 1,528 | +113% | $0 | |
| 2024-06-04 | 2024-05-31 | AMGN | Amgen | Klotman Mary E. | Dir | A - Grant | $0.00 | +719 | 719 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations